Pfizer
Latest statistics and disclosures from Pfizer's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ORIC, ALLO, ARVN, CELC, ZURA, and represent 79.80% of Pfizer's stock portfolio.
- Added to shares of these 1 stock: AgomAb Therapeutics NV.
- Started 1 new stock position in AgomAb Therapeutics NV.
- Reduced shares in these 6 stocks: ORIC (-$7.2M), CELC (-$5.7M), QTTB, ANTX, ZURA, NXTC.
- Sold out of its position in ANTX.
- Pfizer was a net seller of stock by $-15M.
- Pfizer has $239M in assets under management (AUM), dropping by 0.98%.
- Central Index Key (CIK): 0000078003
Tip: Access up to 7 years of quarterly data
Positions held by Pfizer consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Pfizer
Pfizer holds 18 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Oric Pharmaceuticals (ORIC) | 24.1 | $58M | -11% | 4.8M | 12.06 |
|
| Allogene Therapeutics (ALLO) | 20.9 | $50M | 22M | 2.26 |
|
|
| Arvinas Ord (ARVN) | 14.6 | $35M | 3.5M | 10.10 |
|
|
| Celcuity (CELC) | 13.1 | $31M | -15% | 296k | 106.02 |
|
| Zura Bio Class A Ord Shs (ZURA) | 7.1 | $17M | -4% | 2.8M | 5.93 |
|
| Wave Life Sciences SHS (WVE) | 5.0 | $12M | 1.9M | 6.37 |
|
|
| Pyxis Oncology Common Stock (PYXS) | 3.9 | $9.2M | 7.0M | 1.31 |
|
|
| Caribou Biosciences (CRBU) | 3.5 | $8.3M | 4.7M | 1.78 |
|
|
| Spero Therapeutics (SPRO) | 2.3 | $5.5M | 2.4M | 2.33 |
|
|
| Biohaven (BHVN) | 1.8 | $4.2M | 506k | 8.37 |
|
|
| Cardiff Oncology (CRDF) | 1.6 | $3.7M | 2.4M | 1.55 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 0.8 | $2.0M | 954k | 2.10 |
|
|
| Nextcure Com New (NXTC) | 0.6 | $1.5M | -2% | 153k | 10.01 |
|
| Agomab Therapeutics Nv Ads | 0.3 | $814k | NEW | 75k | 10.85 |
|
| Q32 Bio (QTTB) | 0.3 | $737k | -63% | 102k | 7.25 |
|
| Bolt Biotherapeutics Com New (BOLT) | 0.1 | $137k | 31k | 4.38 |
|
|
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.0 | $17k | 2.9k | 5.93 |
|
|
| Senseonics Hldgs | 0.0 | $14k | 2.2k | 6.56 |
|
Past Filings by Pfizer
SEC 13F filings are viewable for Pfizer going back to 2025
- Pfizer 2026 Q1 filed May 12, 2026
- Pfizer 2025 Q4 filed Feb. 12, 2026
- Pfizer 2025 Q3 filed Nov. 13, 2025
- Pfizer 2025 Q2 filed Aug. 11, 2025
- Pfizer 2025 Q1 filed May 13, 2025